Clinical and histopathologic features of hair loss in patients with HIV-1 infection

Journal of the American Academy of Dermatology

Volumn 34, Issue 1, 1996, Pages 63-68

  Smith, Kathleen J ^a,d   Skelton, Henry G ^c   DeRusso, Deanna ^b   Sperling, Leonard ^g   Yeager, Josef ^e   Wagner, Kenneth F ^f   Angritt, Peter ^g  

^a U States Army Med Res Inst C   (United States)

^b GEORGETOWN UNIVERSITY   (United States)

^c ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

^d AIDS Registry   (United States)

^e WALTER REED ARMY MEDICAL CENTER   (United States)

^f HENRY M JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE   (United States)

^g Mil Med Consortium Adv R

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERMEDIN; ANDROGEN; COPPER; CYSTINE; CYTOKINE; ESTRADIOL; HYDROCORTISONE; INTERLEUKIN 10; INTERLEUKIN 4; INTERLEUKIN 6; SELENIUM; THYROID HORMONE; TUMOR NECROSIS FACTOR ALPHA; ZINC;

ARTICLE; CHRONIC DISEASE; CLINICAL ARTICLE; DISEASE PREDISPOSITION; DYSTROPHY; FEMALE; HAIR ANALYSIS; HAIR GROWTH; HAIR LOSS; HISTOPATHOLOGY; HORMONAL REGULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFLAMMATORY INFILTRATE; LEUKOCYTE COUNT; MALE; PRIORITY JOURNAL; PROTEIN MALNUTRITION; SCALP; SKIN BIOPSY;

EID: 0030042871     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0190-9622(96)90835-X     Document Type: Article

References (51)

1. Sadick NS. Clinical and laboratory evaluation of AIDS trichopathy. Int J Dermatol 1993;32:33-8.
2. Prose NS, Abson KG, Scher RK. Disorders of the nails and hair associated with human immunodeficiency virus infection. Int J Dermatol 1992;31:453-7.
3. Catania A, Airaghi L, Manfredi MG, et al. Propriomelancortin-derived peptides and cytokines: relations in patients with acquired immunodeficiency syndrome. Clin Immunol Immunopathol 1993;66:73-9.
4. Hughes TK, Hashemi F, Stefano GB. Immunosuppressive effects of corticotropin and melanotropin and their possible significance in human immunodeficiency virus infection. Proc Natl Acad Si U S A 1992;89:782-6.
5. Membreno L, Irony I, Dere W, et al. Adrenocortical function in acquired immunodeficiency syndrome. J Clin Endocrinol 1987;65:482-7.
6. Christeff N, Gharakhanian S, Thobie N, et al. Evidence for changes in adrenal and testicular steroids during HIV infection. J Acquir Immune Defic Syndr 1992;5:841-6.
7. Coodley GO, Loveless MO, Nelson HD, et al. Endocrine function in the HIV wasting syndrome. J Acquir Immune Defic Syndr 1994;7:46-51.
8. Coodley GO, Loveless MO, Merrill TM. The HIV wasting syndrome: a review. J Acquir Immune Defic Syndr 1994;7:681-94.
9. Summerball C. Appetite and nutrition in relation to human immunodeficiency virus (HIV) infection and acquired immunodeficiency virus syndrome (AIDS). Proc Nutr Soc 1994;53:139-50.
10. Graham NMH, Odaka N, Broodmeyer R, et al. Relationship of serum copper and zinc levels in HIV-1 seropositivity and progression to AIDS. J Acquir Immune Defic Syndr 1991;4:976-80.
11. Dworkin BM. Selenium deficiency in HIV infection and the acquired immunodeficiency syndrome (AIDS). Chem Biol Interact 1994:91:181-6.
12. Favier A, Sappey C, Leclerc P, et al. Antioxidant status and lipid peroxidation in patients infected with HIV. Chem Biol Interact 1994;91:165-80.
13. Greenspan HC, Aruoma OI. Oxidative stress and apoptosis in HIV infection: a role for plant-derived metabolites with synergistic antioxidant activity. Immunol Today 1994;15:209-13.
14. Stewart MI, Smoller BR. Alopecia universalis in an HIV-positive patient: possible insight into pathogenesis. J Cutan Pathol 1993;20:180-3.
15. Lafeuillade A, Quilichini R, Chaffanjon P, et al. Alopecia universalis in a homosexual man seropositive for the human immunodeficiency virus [Letter]. J Acquir Immune Defic Syndr 1990;3:1019.
16. Schonwetter RS, Nelson EB. Alopecia areata and the acquired immunodeficiency syndrome-related complex [Letter]. Ann Intern Med 1986;104:287.
17. Casanonva JM, Puig T, Rubino M. Hypertrichosis of the eyelashes in acquired immunodeficiency syndrome [Letter]. Arch Dermatol 1987;123:1599-601.
18. Leonidas JR. Hair alteration in black patients with the acquired immunodeficiency syndrome. Cutis 1987;39:537-8.
19. Saraux A, Taelman H, Batungwanayo J, et al. High predictive value of straightened hair for HIV infection in the adult population of Central Africa. Ann Dermatol Venereol 1993:120:395-6.
20. Brocker EB, Echternacht-Happle K, Hamm H, et al. Abnormal expression of Class I and Class II major histocompatibility antigens in alopecia areata: modulation by topical immunotherapy. J Invest Dermatol 1987;88:564-8.
21. Khoury EL, Price VP, Greenspan JS. HLA-DR expression by hak follicle keratinocytes in alopecia areata: evidence that it is secondary to the lymphoid infiltration. J Invest Dermatol 1988;90:193-200.
22. Messenger AG, Bleehen SS. Expression of HLA-DR by anagen hair follicles in alopecia areata. J Invest Dermatol 1985;85:569-72.
23. Ascher MS, Sheppard HW. Immune system activation: II. the anergic amnesia hypothesis. J Acquir Immune Defic Syndr 1990;3:177-91.
24. Barker JNWN, MIRA RS, Griffith CEM, et al. Keratinocytes as initiators of inflammation. Lancet 1991;337: 211-4.
25. Guttendorf RJ, Wedlund PJ. Genetic aspects of drug disposition and therapeutics. J Clin Pharmacol 1992;32:107-17.
26. Darr D, Fridovich I. Free radicals in cutaneous biology. J Invest Dermatol 1994;102:671-5.
27. Trenam CW, Blake DR, Morris CJ. Skin inflammation: reactive oxygen species and the role of iron. J Invest Dermatol 1992;99:675-82.
28. Yannicelli S, Hambidge KM, Picciano MF. Decreased selenium intake and low plasma selenium concentrations leading to clinical symptoms in a child with propionic acidaemia. J Inherit Metab Dis 1992;15:261-8.
29. Dupre A, Bonafe JL, Carriere JP. The hair in acrodermatitis enteropathica: A disease indicator? Acta Derm Venereol 1979;59:59-60.
30. Price VH. Structural anomalies of the hair shaft. In: Orfanos CE, ed. Hair and hair diseases. New York: Springer-Verlag, 1989:363-422.
31. Coldrin BM, Bergstresser PR. Prevalence and clinical spectrum of skin disease in patients infected with human immunodeficiency virus. Arch Dermatol 1989;12:357-61.
32. Fisher AK, Warner LC. Cutaneous manifestations of the acquired immunodeficiency syndrome: update 1987. Int J Dermatol 1987;26:615-30.
33. Dezube BJ, Pardee AB, Beckett LA, et al. Cytokine dysregulation in AIDS: in vivo overexpression of mRNA of tumor necrosis factor-alpha and its correlation with that of the inflammatory cytokine GRO. J Acquir Immune Defic Syndr 1992;8:1099-1104.
34. Breen EC, Rezai AR, Nakajima K, et al. Infection with HIV is associated with elevated IL-6 levels and production. J Immunol 1990;144:480-4.
35. Turksen K, Kupper T, Degenstein L, et al. Interleukin 6: insights to its function in skin by overexpression in transgenic mice. Proc Natl Acad Sci U S A 1992;89:5068-72.
36. Harindra V, Sivapalan S, Basu Roy R. Increased nail and hair growth in a patient with AIDS. Br J Clin Pract 1992;47:2215-6.
37. Hortin GL, Landt M, Powderly WG. Changes in amino acid concentrations in response to HIV-1 infection. Clin Chem 1994;40:785-9.
38. Clerici M, Shearer GM. A Th1 to Th2 switch is a critical step in the etiology of HIV infection. Immunol Today 1993;14:107-10.
39. Buhl R, Jaffe HA, Holrodyd KJ, et al. Systemic glutathione deficiency in symptom-free HIV sero-positive individuals. Lancet 1989;2:1294-8.
40. Eck H-P, Gmunder H, Harmann M, et al. Low concentrations of acid soluble thiol (cysteine) in the blood plasma of HIV-1 infected patients. Biol Chem Hoppe Seyler 1989; 370:101-8.
41. Masutani H, Naito M, Takahashi K, et al. Dysregulation of adult T-cell leukemia-derived factor (ADF)-thioredoxin in HIV infection: loss of ADF high-producer cells in lymphoid tissues of AIDS patients. AIDS Res Hum Retroviruses 1992;8:1707-15.
42. Flores SC, Marecki JC, Harper KP, et al. Tat protein of human immunodeficiency virus 1 respresses expression of manganese superoxide dismutase in HeLa cells. Proc Natl Acad Sci U S A 1993;90:7632-6.
43. Sandstrom PA, Buttke TM. Autocrine production of extracellular catalase prevents apoptosis of the human CEM T-cell line in serum-free medium. Proc Natl Acad Sci U S A 1993;90:4708-12.
44. Dezube BJ, Pardee AB, Beckett LA, et al. Cytokine dysregulation in AIDS: in vivo overexpression of mRNA of tumor necrosis factor-alpha and its correlation with that of the inflammatory cytokine GRO. J Acquir Immune Defic Syndr 1992;5:1099-104.
45. Schreck R, Rieber P, Bawuerle PA. Reactive oxygen intermediates as apparently widely used messenger in the activation of the NF-kB transcription factor and HIV-1. EMBO J 1991;10:2247-58.
46. Staal FJT, Roederer M, Herzenberg LA, et al. Intracellular thiols regulate activation of nuclear factor kB and transcription of human immunodeficiency virus. Proc Natl Acad Sci U S A 1990;87:9943-7.
47. Headington JT. Telogen effluvium. Arch Dermatol 1993; 129:356-63.
48. Halliwell B. Reactive oxygen species in pathology with special reference to the skin. In: Fuchs J, Packer L, eds. Oxidative stress in dermatology. New York: Marcel Dekker, 1993:3-11.
49. Sale GE, Beauchamp M. Parafollicular bulge in human GVHD: a stem cell-rich primary target. Transplant 1993; 11:223-5.
50. Murphy GF, Lavker RM, Whitaker D, et al. Cytotoxic folliculitis in GvHD: evidence of follicular stem cell injury and recovery. J Cutan Pathol 1991;18:309-14.
51. Dalgleish AG, Colizzi V. Role of major histocompatibility complex recognition in the protection and immunopathogenesis of AIDS. AIDS 1992;6:523-5.